All News

New app may improve directly observed therapy adherence for TB, opioid abuse treatment, and diabetes.

Gerry Crocker talks with Drug Topics on his plans to grow the Association of Affiliated Pharmacies and Apothecaries (AAPArx).

Alembic Pharmaceuticals and MacLeods Pharmaceuticals have drastically increased prices as competition in valsartan and related medications was hindered by 2018 recalls.

Healthcare trails only behind retail (Walmart) as the top employment sector in America.

Using Blockchain technology, the new program will legally redispense expensive medications to those who cannot afford them.

Proposed HHS regulation would pass rebates on to consumers

Four steps that compounding pharmacists must take to restore their credibility.

What needs to be considered before independent and chain pharmacies branch into the specialty arena. 

How you can manage these stereotypes found in the pharmacy workplace.

Whistleblower prompts investigation into inflated prices that began in 2012.

One of our columnists recounts his major New Years moments and offers 2019 hopes for the pharmacy profession. 

A Rapid Credit program is a powerful enhancement to reverse distribution services.

Follow these pharmacists to spice up your news feed with more pharmacy-related content.

Rounding up the news you need to know to start the new year.

The dispute between the two companies highlights ongoing frustrations with the PBM model.

Approved and upcoming drugs to look forward to this year.

Walgreens locations, Duane Reade stores, and Walgreens Boots Alliance distribution centers will move workflows to Microsoft’s Azure cloud and AI tool.

Black patients with atrial fibrillation are less likely to be treated with oral anticoagulants or DOACs.

Organ function changes require regular monitoring, counseling

Standing behind the counter and waiting for customers to walk into your pharmacy is not enough to sustain independents in today’s marketplace. Here are some new or unique things independents should consider to ensure survival, says B. Douglas Hoey, RPh, MBA, CEO of the NCPA.

The risk of gastrointestinal bleeding appears to be highest with rivaroxaban and lowest with apixaban, but is reduced by cotherapy with proton pump inhibitors.

Changes coming to combat opioid addictions and overuse, as well as mitigate rising drug prices. 

Growth of hospital emergency departments includes delivery of primary care and medication management, necessitating pharmacist involvement.

FDA, CDC, and DEA are still supporting pharmacists during the federal shutdown

Most Ritzman Pharmacy stores will be shuttered.